{"@id":"https://bioecon.ru/technology/viral-vectored-neoantigen-vaccines/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://en.bioecon.ru/technology/viral-vectored-neoantigen-vaccines/","json":"https://en.bioecon.ru/api/v1/technology/viral-vectored-neoantigen-vaccines/index.json"},"id":"viral-vectored-neoantigen-vaccines","industries":["pharma","biomanufacturing"],"lang":"en","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/genscript-probio-genscript/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/vaksindo-animal-health/","https://bioecon.ru/companies/esco-aster/","https://bioecon.ru/companies/vaxxinova-norway/","https://bioecon.ru/companies/ridgeway-biologicals/","https://bioecon.ru/companies/gsk/"]},"maturity":7,"name":"Viral-Vectored Neoantigen Vaccines","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Neoantigen computational prediction"},{"n":2,"title":"Multi-epitope cassette design"},{"n":3,"title":"Replication-deficient viral packaging"},{"n":4,"title":"Heterologous prime-boost immunization"}],"summary":"Replication-deficient chimpanzee adenoviral (ChAd) and modified vaccinia Ankara (MVA) heterologous prime-boost vaccine platforms encoding computationally predicted, multi-epitope personalized neoantigen cassettes, inducing high-frequency polyfunctional CD8+ and CD4+ T-cell antitumor responses.","url":"/technology/viral-vectored-neoantigen-vaccines/","verified":"2026-11-22"}